[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611535":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":23,"collaborators":7,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":7,"eligibilityCriteria":33,"healthyVolunteers":34,"sex":35,"minAge":36,"maxAge":7,"enrollmentInfo":37,"targetDuration":40,"studyType":41,"phases":7,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":47,"whyStopped":7,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"RADIATION","OCT","All the patients will undergo OCT imaging using NIDEK RS-330 Retina scan duo 2 (SD-OCT)(CO-LTD made in Japan 2017) with scan speed 70.000 axial scans per second and wavelength of 880 nm. A three-dimensional scan protocol will be used for macular measurements. Macular scans will be performed with axial scanning protocols covering a 9 × 9 mm area centered on the fovea.\n\nOCT images will be evaluated by a trained ophthalmologist for the following:\n\n\\- Stage of ERM will be classified by Govetto et al system into stage 1,2,3 or 4.\n\nStage 1: ERMs were mild and thin. Foveal depression is present. Stage 2: ERMs with a widening of the outer nuclear layer and loss of the foveal depression.\n\nStage 3: ERMs with continuous ectopic inner foveal layers crossing the entire foveal area.\n\nStage 4: ERMs were thick with continuous ectopic inner foveal layers and disrupted retinal layers.\n\n\\- central macular thickness CMT",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"merna maged, resident doctor","CONTACT","+201284143158","mernamaged1@gmail.com",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"salma kedwany, MD","+201062330885","salmakedwany@aun.edu.eg",{"type":24,"investigatorFullName":25,"investigatorTitle":26,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Merna Maged Monir Aziz","resident doctor","100611535","epiretinal-membrane-in-patients-with-dr-100611535",false,"NCT07241845","Epiretinal Membrane in Patients With DR.","Epiretinal Membrane in Patients With Diabetic Retinopathy.","Inclusion Criteria:\n\n* Patients aged 18 years or older.\n* Patients with ERM confirmed by OCT images.\n* Patients with DM with varying severity of diabetic retinopathy.\n\nExclusion Criteria:\n\n* • History of previous eye trauma or surgery other than uneventful cataract surgery, uveitis, history of retinal detachment, media opacity impairing the quality OCT images, high myopia, macular or retinal diseases disease affecting the visual acuity other than diabetic retinopathy, e.g. macular hole, retinitis pigmentosa, AMD, CRVO.",true,"ALL","18 Years",{"count":38,"type":39},225,"ESTIMATED","1 Year","OBSERVATIONAL","To report the prevalence of ERM among patients with diabetic retinopathy, and the possible associated risk factors.",[44],"Epiretinal Membrane",[46],"oct","NOT_YET_RECRUITING","2025-11-17",{"date":50,"type":51},"2025-11-21","ACTUAL",{"date":53,"type":39},"2026-01",{"date":55,"type":39},"2028-10",{"name":5,"class":6}]